Routine antenatal anti‐D prophylaxis – is the protection adequate?
- 9 September 2011
- journal article
- research article
- Published by Wiley in Transfusion Medicine
- Vol. 21 (6) , 421-426
Abstract
Prophylactic anti-D given during pregnancy can be detected in current indirect antiglobulin tests (IAT). Using this to measure the persistence of prophylactic anti-D, this study set out to determine whether there is an association between anti-D detectable at delivery and the RhD status of the foetus and/or the duration of the pregnancy post the standard 28 week dose of routine antenatal anti-D prophylaxis (RAADP). The study also investigated the detection rates of anti-D at delivery when given in a two dose regime or a one dose regime. All IAT screening was undertaken using fully automated Diamed gel technology. The results from 407 women were included in the two dose regime study, and 157 in the one dose regime study. 160/407 (39%) women receiving one dose of prophylactic anti-D had no detectable anti-D at delivery. 123/157 (78%) women on the one dose regime had no detectable anti-D at delivery. No association was found between detectable anti-D at delivery and the RhD status of the infant in either study arm. A strong association was found between detectable anti-D Ig at delivery and the duration of the pregnancy post the 28 week dose in each study arm. Our data show that neither the two dose nor the one dose regime appear to provide adequate cover at delivery for a large percentage of pregnant women. This appears to be associated with the duration of the pregnancy past the 28 week dose but not associated with the RhD status of the foetus.Keywords
This publication has 20 references indexed in Scilit:
- Risk factors for RhD immunisation despite antenatal and postnatal anti‐D prophylaxisBJOG: An International Journal of Obstetrics & Gynaecology, 2009
- Guideline for blood grouping and antibody testing in pregnancyTransfusion Medicine, 2007
- General obstetrics: The kinetics of routine antenatal prophylactic intramuscular injections of polyclonal anti‐D immunoglobulinBJOG: An International Journal of Obstetrics & Gynaecology, 2005
- Guidelines for blood grouping and red cell antibody testing during pregnancyTransfusion Medicine, 1996
- A retrospective study to determine the risk of red cell alloimmunization and transfusion during pregnancyTransfusion, 1993
- Towards the conquest of Rh haemolytic disease: Britain's contribution and the role of serendipity*Transfusion Medicine, 1992
- Efficacy and long term effects of antenatal prophylaxis with anti-D immunoglobulin.BMJ, 1989
- THE YORKSHIRE ANTENATAL ANTI-D IMMUNOGLOBULIN TRIAL IN PRIMIGRAVIDAEThe Lancet, 1983
- Immunization of Rh‐Negative Volunteers by Repeated Injections of Very Small Amounts of Rh‐Positive BloodVox Sanguinis, 1972
- Primary Immunization of Rh-negative VolunteersBMJ, 1970